Cardio Diagnostics Holdings Inc. Common stock Share Price
CDIOCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $2.00 | Prev. Close $1.96 | Circuit Range N/A |
Day Range $1.93 - $2.00 | Year Range $0.97 - $7.89 | Volume 213 |
Average Traded $1.97 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jun-26 | $2.00 | $1.97 | +0.00% |
09-Jun-26 | $2.00 | $1.97 | +0.51% |
08-Jun-26 | $2.00 | $1.96 | -0.51% |
05-Jun-26 | $2.06 | $1.97 | -7.29% |
04-Jun-26 | $2.13 | $2.13 | -2.07% |
03-Jun-26 | $2.23 | $2.17 | -6.47% |
02-Jun-26 | $2.15 | $2.32 | +7.16% |